Gastrointestinal and Health-related Quality of Life in Kidney Transplant Patients Treated With Mycophenolate Mofetil

NCT00400647 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

136

Enrollment

INDUSTRY

Sponsor class

Conditions

Maintenance Kidney Transplant

Interventions

DRUG: Enteric-coated Mycophenolate sodium (EC-MPS)
DRUG: Mycophenolate mofetil

Sponsor

Novartis